Department of Tumor Biology
Department Head: Professor Øystein Fodstad, MD, PhD
Department Acting Head: Senior scientist Gunhild M. Mælandsmo, PhD
Department of Tumour Biology comprises five research groups:
- Biology of metastasis: functional, diagnostic and therapeutic aspects, headed by Professor Øystein Fodstad (MD, PhD)
- Metastasis: molecular studies and development of methods, headed by senior scientist Eivind Hovig (PhD)
- Molecular characterization of mesenchymal cancer development, headed by professor Ola Myklebost (PhD)
- Metastasis: biology and therapy, headed by senior scientist Gunhild M. Mælandsmo (PhD)
- Group of Urological Molecular Biology, headed by adjunct professor Kristin Austlid Taskén
|
|
| ![]() | |
| Eivind Hovig | Ola Myklebost | G.M. Mælandsmo | Kristin A. Taskén |
Project groups:
| Mesenchymal genomics | Anti-cancer therapy with immunotoxin | ||
|
| ||
| Yvonne Andersson |
The scientific focus of Department of Tumour Biology is on studies of mechanisms involved in cancer development and progression. In that regard we have two main interests:
- investigations of basic biology
- development of new and better methods in the fields of diagnosis, prognosis and therapy
The department has participated considerably in the establishment of the Microarray technology (Go to the Priority Area Web Pages for further reading), development of Bioinformatics, as well as the Gene Therapy Program at the Norwegian Radium Hospital.
May 7, 2012
Latest publications
Dept. of Tumor Biology
Synthesis of Highly Efficient, Ca-Based, Al(2) O(3) -Stabilized, Carbon Gel-Templated CO(2) Sorbents
Adv Mater (in press)
PubMed 22570251
Erratum to: Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
Tumour Biol (in press)
PubMed 22562266
Public health. Monitoring EU emerging infectious disease risk due to climate change
Science, 336 (6080), 418-9
PubMed 22539705











Print this page
